>
"They Think There Are Too Many Of Us On The Planet" - Alex Newman Warns Of Tyrannical...
Aussie Senator Says Elon Musk Should "Be In Jail And The Key Be Thrown Away"
Chinese Have "Grabbed Gold By The Throat" As Capital Flight Accelerates
Hong Kong Bitcoin And Ether ETFs Officially Approved To Start Trading On April 30
Blazing bits transmitted 4.5 million times faster than broadband
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
Developed by scientists from North Carolina State University and the University of North Carolina at Chapel Hill, the system incorporates porous hydrogel nanospheres.
Measuring about 250 nanometers in diameter, each sphere contains a drug/protein known as Y-27632 at its core, which is surrounded by a layer of another drug called tPA (tissue plasminogen activator). On the outside of each sphere is a coating of proteins that bind specifically to fibrin, a protein which is a key component of blood clots.
When injected into a vein, the nanospheres flow freely through the patient's bloodstream until encountering a clot, which they stick to. The tPA then proceeds to leak out, breaking down the fibrin and thus dissolving the clot.